Safi R Bahcall Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Safi R Bahcall.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Safi R Bahcall. Safi R Bahcall is President and CEO in SYNTA PHARMACEUTICALS CORP ($SNTA).
Latest Insider Trading Transactions of Safi R Bahcall
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 15 2013 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Buy | P | 3.75 | 20,000 | 75,000 | 2,053,135 | 2 M to 2.1 M (+0.98 %) |
| Jul 01 2013 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Buy | P | 5.03 | 10,000 | 50,299 | 2,033,135 | 2 M to 2 M (+0.49 %) |
| Jun 24 2013 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Buy | P | 4.12 | 20,000 | 82,374 | 2,023,135 | 2 M to 2 M (+1.00 %) |
| Jun 17 2013 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Buy | P | 4.06 | 10,000 | 40,550 | 2,003,135 | 2 M to 2 M (+0.50 %) |
| Jun 06 2013 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Buy | P | 4.04 | 10,000 | 40,390 | 1,993,135 | 2 M to 2 M (+0.50 %) |
| Mar 07 2013 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Option Exercise | A | 9.65 | 230,000 | 2,219,500 | 230,000 | |
| Dec 14 2012 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Grant | A | 8.60 | 10,000 | 86,000 | 2,383,135 | 2.4 M to 2.4 M (+0.42 %) |
| Nov 13 2012 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Buy | P | 7.12 | 10,000 | 71,200 | 2,373,135 | 2.4 M to 2.4 M (+0.42 %) |
| Sep 17 2012 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Option Exercise | A | 8.05 | 100,000 | 805,000 | 100,000 | |
| Jul 27 2012 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Grant | A | 6.49 | 20,000 | 129,800 | 2,363,135 | 2.3 M to 2.4 M (+0.85 %) |
| Jul 02 2012 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Buy | P | 5.34 | 10,000 | 53,370 | 2,343,135 | 2.3 M to 2.3 M (+0.43 %) |
| Mar 08 2012 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Option Exercise | A | 4.22 | 185,000 | 780,700 | 185,000 | |
| Mar 15 2011 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Buy | P | 4.45 | 5,000 | 22,250 | 2,333,135 | 2.3 M to 2.3 M (+0.21 %) |
| Mar 03 2011 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Option Exercise | A | 5.26 | 200,000 | 1,052,000 | 200,000 | |
| Mar 03 2011 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Grant | A | 0.00 | 11,549 | 0 | 2,328,135 | 2.3 M to 2.3 M (+0.50 %) |
| Jun 10 2010 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Buy | P | 3.05 | 10,000 | 30,530 | 2,316,586 | 2.3 M to 2.3 M (+0.43 %) |
| Mar 03 2010 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Option Exercise | A | 4.02 | 160,000 | 643,200 | 160,000 | |
| Mar 03 2010 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Grant | A | 0.00 | 13,839 | 0 | 2,306,586 | 2.3 M to 2.3 M (+0.60 %) |
| Jan 12 2010 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Buy | P | 4.50 | 22,222 | 99,999 | 2,292,747 | 2.3 M to 2.3 M (+0.98 %) |
| Aug 07 2009 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Buy | P | 2.89 | 9,245 | 26,718 | 2,270,525 | 2.3 M to 2.3 M (+0.41 %) |
| Aug 07 2009 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Buy | P | 2.88 | 196 | 564 | 2,261,280 | 2.3 M to 2.3 M (+0.01 %) |
| Aug 07 2009 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Buy | P | 2.85 | 2,000 | 5,700 | 2,261,084 | 2.3 M to 2.3 M (+0.09 %) |
| Aug 07 2009 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Buy | P | 2.83 | 1,980 | 5,603 | 2,259,084 | 2.3 M to 2.3 M (+0.09 %) |
| Aug 07 2009 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Buy | P | 2.82 | 300 | 846 | 2,257,104 | 2.3 M to 2.3 M (+0.01 %) |
| Aug 07 2009 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Buy | P | 2.80 | 6,079 | 17,021 | 2,256,804 | 2.3 M to 2.3 M (+0.27 %) |
| Aug 07 2009 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Buy | P | 2.78 | 200 | 556 | 2,250,725 | 2.3 M to 2.3 M (+0.01 %) |
| Apr 14 2009 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Option Exercise | A | 2.49 | 146,300 | 364,287 | 146,300 | |
| Feb 29 2008 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Option Exercise | A | 8.82 | 100,000 | 882,000 | 100,000 | |
| Nov 26 2007 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Buy | P | 7.83 | 5,000 | 39,141 | 2,250,525 | 2.2 M to 2.3 M (+0.22 %) |
| Feb 28 2007 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Option Exercise | A | 8.53 | 46,000 | 392,380 | 46,000 |
Page: 1